Adoprazine is a chemical compound classified as an atypical antipsychotic, primarily investigated for its potential therapeutic effects in treating schizophrenia and other psychiatric disorders. It functions as a dopamine D2 receptor antagonist, which helps modulate dopaminergic activity in the brain, potentially alleviating symptoms associated with psychosis. Adoprazine also exhibits activity at various other neurotransmitter receptors, including serotonin receptors, which may contribute to its efficacy and side effect profile. The compound is characterized by its relatively low affinity for histamine and adrenergic receptors, which may reduce the likelihood of certain side effects commonly associated with other antipsychotics. Its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion, are crucial for determining its clinical application and dosing regimen. Ongoing research continues to explore its safety, efficacy, and potential advantages over existing antipsychotic medications. As with any pharmacological agent, understanding its mechanism of action and side effects is essential for optimizing therapeutic outcomes in patients.

Adoprazine

222551-17-9: Adoprazine is a chemical compound classified as an atypical antipsychotic, primarily investigated for its potential therapeutic effects in treating schizophrenia and other psychiatric disorders. It functions as a dopamine D2 receptor antagonist, which helps modulate dopaminergic activity in the brain, potentially alleviating symptoms associated with psychosis. Adoprazine also exhibits activity at various other neurotransmitter receptors, including serotonin receptors, which may contribute to its efficacy and side effect profile. The compound is characterized by its relatively low affinity for histamine and adrenergic receptors, which may reduce the likelihood of certain side effects commonly associated with other antipsychotics. Its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion, are crucial for determining its clinical application and dosing regimen. Ongoing research continues to explore its safety, efficacy, and potential advantages over existing antipsychotic medications. As with any pharmacological agent, understanding its mechanism of action and side effects is essential for optimizing therapeutic outcomes in patients.

<p>Adoprazine (SLV313) is a potential atypical antipsychotic bearing potent D2 receptor antagonist and 5-HT1A receptor agonist properties.</p>

CAS 222551-17-9

Adoprazine

Adoprazine

Ref: IN-DA00BF1Z

Adoprazine

Ref: 54-BUP16226

Adoprazine

Ref: TM-T10249